Titan Pharmaceuticals, Inc.
TTNP
$3.70
-$0.09-2.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.12% | -58.02% | 3,797.14% | 442.17% | 130.17% |
| Total Receivables | -94.07% | -96.59% | 322.22% | 1,575.00% | 2,805.56% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -84.92% | -38.11% | -3.93% | -21.67% | -36.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -93.81% |
| Total Current Assets | -63.54% | -63.61% | 773.49% | 270.36% | 122.54% |
|
|
|||||
| Total Current Assets | -63.54% | -63.61% | 773.49% | 270.36% | 122.54% |
| Net Property, Plant & Equipment | -- | -- | -- | -89.55% | -83.29% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -63.85% | -63.98% | 435.71% | 206.55% | 99.26% |
|
|
|||||
| Total Accounts Payable | -41.95% | -8.85% | -40.37% | -34.57% | -49.93% |
| Total Accrued Expenses | -45.86% | -- | -- | -89.46% | -65.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -73.60% | -46.72% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -96.31% |
| Total Other Current Liabilities | -- | -- | -- | -- | -96.31% |
| Total Current Liabilities | -66.55% | -80.12% | -80.72% | -77.16% | -45.10% |
|
|
|||||
| Total Current Liabilities | -66.55% | -80.12% | -80.72% | -77.16% | -45.10% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -66.55% | -80.12% | -80.72% | -77.46% | -46.42% |
|
|
|||||
| Common Stock & APIC | 0.13% | 0.25% | 2.70% | 2.93% | 2.80% |
| Retained Earnings | -1.20% | -1.51% | -1.40% | -1.28% | -1.44% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -63.27% | -60.28% | 486.17% | 2,050.64% | 387.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | -63.27% | -60.28% | 486.17% | 2,050.64% | 387.23% |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -63.26% | -60.27% | 486.27% | 2,050.96% | 387.31% |
|
|
|||||